BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 16107180)

  • 1. Schizophrenia and comorbid substance use disorder: effects of antipsychotics.
    Green AI
    J Clin Psychiatry; 2005; 66 Suppl 6():21-6. PubMed ID: 16107180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
    Green AI
    J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance abuse in schizophrenia: a review.
    Buckley PF
    J Clin Psychiatry; 1998; 59 Suppl 3():26-30. PubMed ID: 9541335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
    San L; Arranz B; Martinez-Raga J
    Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbid schizophrenia and substance abuse.
    Green AI; Brown ES
    J Clin Psychiatry; 2006 Sep; 67(9):e08. PubMed ID: 17081075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of schizophrenia with substance use disorders.
    Lybrand J; Caroff S
    Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.
    Swartz MS; Wagner HR; Swanson JW; Stroup TS; McEvoy JP; Canive JM; Miller DD; Reimherr F; McGee M; Khan A; Van Dorn R; Rosenheck RA; Lieberman JA
    J Nerv Ment Dis; 2006 Mar; 194(3):164-72. PubMed ID: 16534433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
    Volavka J
    J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it time to consider comorbid substance abuse as a new indication for antipsychotic drug development?
    Awad AG
    J Psychopharmacol; 2012 Jul; 26(7):953-7. PubMed ID: 22170735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of comorbid bipolar disorder and substance abuse.
    Vornik LA; Brown ES
    J Clin Psychiatry; 2006; 67 Suppl 7():24-30. PubMed ID: 16961421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of schizophrenia and comorbid substance use disorder.
    Green AI; Salomon MS; Brenner MJ; Rawlins K
    Curr Drug Targets CNS Neurol Disord; 2002 Apr; 1(2):129-39. PubMed ID: 12769622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of dual diagnosis disorders.
    Murthy P; Chand P
    Curr Opin Psychiatry; 2012 May; 25(3):194-200. PubMed ID: 22395768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
    Coulston CM; Perdices M; Tennant CC
    Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obsessive-compulsive disorder in bipolar disorder patients with first manic episode.
    Pashinian A; Faragian S; Levi A; Yeghiyan M; Gasparyan K; Weizman R; Weizman A; Fuchs C; Poyurovsky M
    J Affect Disord; 2006 Aug; 94(1-3):151-6. PubMed ID: 16753221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comorbidity of alcohol-substance use disorders in schizophrenia: a review].
    Evren EC; Evren B
    Turk Psikiyatri Derg; 2003; 14(3):213-24. PubMed ID: 14569472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance abuse in schizophrenia. A Singapore perspective.
    Verma SK; Subramaniam M; Chong SA; Kua EH
    Soc Psychiatry Psychiatr Epidemiol; 2002 Jul; 37(7):326-8. PubMed ID: 12111024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in concomitant medication with benzodiazepines or antidepressants in first-break schizophrenic patients treated with antipsychotic medication.
    Rijcken CA; Knegtering H; Bruggeman R; Tobi H; de Jong-van den Berg LT
    Psychiatry Res; 2005 Apr; 134(2):143-50. PubMed ID: 15840415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.